Australian biotech incubator Proto Axiom announces $20M Series B first close
- Written by PR Newswire Asia - News Pronto RSS
$20M unlocked for opportunities in Australian biotech innovation, valuing Proto Axiom at $90M
SYDNEY, Aug. 13, 2024 /PRNewswire/ -- Proto Axiom, the Australian biomedical technology incubator has today announced a $20 million first close of its targeted $30 million Series B, to bolster Australia's biotechnology (biotech) sector through increased...
Read more: Australian biotech incubator Proto Axiom announces $20M Series B first close